Chris Rogers

Chris Rogers serves as Chief Executive Officer at Exemplar Genetics. Exemplar Genetics operates in the research sector with approximately 16.0 employees. The company is headquartered in Coralville, Iowa. Exemplar Genetics generates annual revenue of 16193000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 357 executive contacts are available in Iowa.
• • Our database includes 201,469 c suite-level executives.

Outlook WordPress.org Shutterstock Gravity Forms Mobile Friendly reCAPTCHA Google Tag Manager

model development housing husbandry preclinical services animal cloning biotechnology research gene-editing minipig models custom models characterization services biosecure facilities translational value human disease modeling improved predictive efficacy animal welfare clinical imaging research outcomes drug discovery therapeutic development regulatory compliance study design fda compliant aaalac accredited biomedical research pharmaceutical testing academic partnerships model characterization standard models research animal care published studies preclinical research model systems human analogs disease foundations experimental models biotechnology genetic modifications research collaborations animal research minipig advantages surgical procedures veterinary care scientific publications compound screening medical imaging endpoint analysis research integrity clinical trials model validation emerging therapies biomedical innovation consultative services analytical techniques health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Chris Rogers in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Exemplar Genetics.

Chris Rogers's Position in the MessageCEO Database

• •Chris Rogers is 1 of 1 verified executive contact we track at Exemplar Genetics.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •343 verified executive contacts in Iowa are in the database.
• •5 verified contacts work at research companies in the 16.0 employee range (same size as Exemplar Genetics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Chris Rogers directly?

Chris Rogers's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Exemplar Genetics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Chris Rogers work for?

Chris Rogers is Chief Executive Officer at Exemplar Genetics, a company in the research sector with 16.0 employees. The company is based in Coralville, Iowa.

Can I pitch or sell to Chris Rogers?

As Chief Executive Officer at Exemplar Genetics, Chris Rogers is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Chris Rogers directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Chris Rogers in?

Chris Rogers works in the research industry as Chief Executive Officer at Exemplar Genetics. MessageCEO provides verified contact information for executives across all major industries.

Is Chris Rogers's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Chris Rogers's profile is kept up-to-date with the latest available information.

Last updated: June 26, 2026